Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Masamichi Komatsu
The Efficacy of Amrubicin Third‐line Chemotherapy in Patients With Relapsed Extensive‐disease Small‐cell Lung Cancer: A Retrospective and Historical Study in a Single Institute
Thoracic Cancer
Medicine
Pulmonary
Respiratory Medicine
Oncology
Related publications
The Safety and Efficacy of Amrubicin in the Treatment of Previously Untreated Extensive-Disease Small-Cell Lung Cancer: A Meta-Analysis
OncoTargets and Therapy
Oncology
Pharmacology
Comparison of Amrubicin and Weekly Cisplatin/Etoposide/Irinotecan in Patients With Relapsed Small-Cell Lung Cancer
Clinical Lung Cancer
Cancer Research
Oncology
Respiratory Medicine
Pulmonary
P1.12-02 Phase II Study of Amrubicin Monotherapy in Elderly or Poor-Risk Patients With Extensive Disease of Small Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Rechallenge With First-Line Platinum Chemotherapy for Sensitive-Relapsed Small-Cell Lung Cancer
Case Reports in Oncology
Oncology
Topotecan Monotherapy for the Treatment of Relapsed Small Cell Lung Cancer in Elderly Patients: A Retrospective Analysis
Thoracic Cancer
Medicine
Pulmonary
Respiratory Medicine
Oncology
Pazopanib Maintenance After First-Line Etoposide and Platinum Chemotherapy in Patients With Extensive Disease Small-Cell Lung Cancer: A Multicentre, Randomised, Placebo-Controlled Phase II Study (KCSG-LU12-07)
British Journal of Cancer
Cancer Research
Oncology
Treatment Results Including More Than Third-Line Chemotherapy for Patients With Advanced Non-Small Cell Lung Cancer
Oncology Letters
Cancer Research
Oncology
P3.01-103 Efficacy of Crizotinib in Chinese Non-Small Cell Lung Cancer Patients With Brain Metastasis: A Multicenter Retrospective Study
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Second-Line Pazopanib in Patients With Relapsed and Refractory Small-Cell Lung Cancer: A Multicentre Phase II Study of the Hellenic Oncology Research Group
British Journal of Cancer
Cancer Research
Oncology
